General information

Governance

Governing Board

Karoline Aebi-Popp MD

Juan Ambrosioni MD

Sanjay Bhagani MD

Christoph Boesecke MD

Deniz Gökengin MD

Justyna Kowalska MD

Agnès Libois MD

Paddy Mallon MD

Esteban Martínez MD

Tetiana Melnyk MD

Silvia Nozza MD
Miłosz Parczewski MD, President

Ann Sullivan MD

Marta Vasylyev MD

Annemarie Wensing MD

Bureau

Miłosz Parczewski, MD, President

Esteban Martínez, MD, Immediat Past President

Christoph Boesecke, MD, Treasurer

Ann Sullivan MD, Secretary

Secretariat

Joëlle Verluyten Executive Director

Gonçalo Lobo Advocacy & Health Policy Consultant

Véronique Van Hal, Administration & Membership Officer

Stephanie Van Meenen, Administrative Assistant

Jasmijn Vervaeck Project & Communications Coordinator

EACS regions

EACS members are divided into 4 scientific regions: Europe-East, Europe-North, Europe-South, Europe-West.

General Assembly

All EACS members who are in good standing may attend the General Assembly and vote.

The EACS General Assembly convenes once a year.

The last EACS General Assembly took place on Monday, 18 November 2024.

View the report

Articles of Association

The Articles of Association are written in the French and English languages. The French version is the official version of the Articles of Association and takes precedence.

English is the working language of EACS.

Statement of

Non-discrimination

20th European AIDS Conference

15-18 October 2025 Paris, France

EACS Guidelines updated

The EACS 12.1 and the app are available for free on

Apple Store and Google Play Store

HIV Summer School 2025, Lyon, France

Applications are now open until 3 March 2025!

More information.

Available here!

Special report on HIV stigma in the healthcare setting

More information

Educational Programme

Training and educating the next generation of clinicians and researchers is an EACS core activity.

EACS Resource Library

Access all scientific content of EACS core activities! (members only)

Interim Guidance

Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV